Main > > >ANEMIA. *

Erythropoiesis-Stimulating Agent.
BioSimilar to Epogen® and Procrit® (Epoetin Alfa)
Indications:
- Chronic Kidney Disease (CKD) in
patients on dialysis and not on
dialysis
- Oncology>ChemoTherapy
- Zidovudine in HIV-infected patients.
USA Approval Date: 2018. 05.15.
(*) Company : Pfizer Inc.
TradeMark: RETACRIT®
UpDate: 2018. 05.16.




Onco.>CT>Anemia. Treat.: DarbEpoietin-Alfa Inj.
Non-Myeloid Cancers.
ReCombinant Long Lasting Erythropoitin.
Sialylated Erythropoietin.
USA Approval Date: ?
(*) Company : Amgen.
Patent : Expired
TradeMark: Aranesp.
Web-Site : www.aranesp.com/
UpDate: 2018. 09.21.




Onco.>CT>Anemia. Treat.: Epoetin Alfa. (U)
Approval Date: ?
ReCombinant Erythropoietin
(*) Companies; Patents; TradeMarks &
Web-Sites Available on Request.
UpDate: 2018. 09.23.




Onco.>CT>Anemia. Treat.: Epoetin Beta. (C)
ReCombinant Erythropoietin.
Approval Date: ?
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 09.18.



>ANEMIA. *'s products
This section has no products